InsidersTradesSigma
Shanghai Junshi Biosciences Co., Ltd. Stock: price and directors' dealings · Hong Kong · HKEX
Follow the Shanghai Junshi Biosciences Co., Ltd. stock price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares are quoted on HK HK, under the oversight of HKEX. Operating in the Health Care sector, Shanghai Junshi Biosciences Co., Ltd. has recorded 5 insider filings. Market capitalisation: €16.8bn. The latest transaction was reported on 8 April 2026 (Purchase). Among the most active insiders: Xiong Jun. All data is openly available.
5
Insider Decl.
0
Thresholds
€11m
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Shanghai Junshi Biosciences Co., Ltd. Strong Buy (bullish), based on 4 analysts. Average price target: HK$29.83.
15Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,494 of 26,212 companies
29.2
score / 100
Value21
Quality38
FCF yld-6.4%
Earn yld-4.2%
EV/EBITDA·
ROE-13%
Gross mgn79%
Net mgn-34%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 8 April 2026
Declarations5 total
894,600 sharesShareXHKGHKEX:DA20260403E00027
Ideal exit: 26 Dec 2026 (T+270)
1,999,513 sharesShareXHKGHKEX:DA20260403E00026
Ideal exit: 26 Dec 2026 (T+270)
5 of 5 declarations